Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $308,447 - $432,426
-588 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$708.84 - $794.68 $476,340 - $534,024
-672 Reduced 53.33%
588 $444,000
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $435,404 - $546,659
-662 Reduced 34.44%
1,260 $940,000
Q2 2021

Aug 13, 2021

SELL
$576.64 - $649.04 $414,604 - $466,659
-719 Reduced 27.22%
1,922 $1.24 Million
Q1 2021

May 14, 2021

BUY
$547.01 - $662.35 $191,453 - $231,822
350 Added 15.28%
2,641 $1.51 Million
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $648,052 - $816,538
1,269 Added 124.17%
2,291 $1.34 Million
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $464,427 - $547,383
1,022 New
1,022 $527,000
Q4 2019

Feb 13, 2020

SELL
$319.73 - $374.2 $115,742 - $135,460
-362 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$304.55 - $345.24 $110,247 - $124,976
362 New
362 $120,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.24B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Fort, L.P. Portfolio

Follow Fort, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Fort, L.P. with notifications on news.